{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:17:32Z","timestamp":1791346652965,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transcription factor EB (TFEB) is a master transcriptional regulator playing a key role in lysosomal biogenesis, autophagy and lysosomal exocytosis. TFEB activity is inhibited following its phosphorylation by mammalian target of rapamycin complex 1 (mTORC1) on the surface of the lysosome. Phosphorylated TFEB is bound by 14-3-3 proteins, resulting in its cytoplasmic retention in an inactive state. It was suggested that the calcium-dependent phosphatase calcineurin is responsible for dephosphorylation and subsequent activation of TFEB under conditions of lysosomal stress. We have recently demonstrated that TFEB is activated following exposure of cancer cells to lysosomotropic anticancer drugs, resulting in lysosome-mediated cancer drug resistance via increased lysosomal biogenesis, lysosomal drug sequestration, and drug extrusion through lysosomal exocytosis. Herein, we studied the molecular mechanism underlying lysosomotropic-drug-induced activation of TFEB. We demonstrate that accumulation of lysosomotropic drugs results in membrane fluidization of lysosome-like liposomes, which is strictly dependent on the acidity of the liposomal lumen. Lysosomal accumulation of lysosomotropic drugs and the consequent fluidization of the lysosomal membrane, facilitated the dissociation of mTOR from the lysosomal membrane and inhibited the kinase activity of mTORC1, which is necessary and sufficient for the\u00a0rapid translocation of TFEB to the nucleus. We further show that while lysosomotropic drug sequestration induces Ca<jats:sup>2+<\/jats:sup> release into the cytoplasm, facilitating calcineurin activation, chelation of cytosolic Ca<jats:sup>2+<\/jats:sup>, or direct inhibition of calcineurin activity, do not interfere with drug-induced nuclear translocation of TFEB. We thus suggest that lysosomotropic drug-induced activation of TFEB is mediated by mTORC1 inhibition due to lysosomal membrane fluidization and not by calcineurin activation. We further postulate that apart from calcineurin, other constitutively active phosphatase(s) partake in TFEB dephosphorylation and consequent activation. Moreover, a rapid export of TFEB from the nucleus to the cytosol occurs upon relief of mTORC1 inhibition, suggesting that dephosphorylated TFEB constantly travels between the nucleus and the cytosol, acting as a rapidly responding sensor of mTORC1 activity.<\/jats:p>","DOI":"10.1038\/s41419-018-1227-0","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T10:23:51Z","timestamp":1544696631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity"],"prefix":"10.1038","volume":"9","author":[{"given":"Benny","family":"Zhitomirsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yunaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kreiserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-8221","authenticated-orcid":false,"given":"Yehuda G.","family":"Assaraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"1227_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jps.20792","volume":"96","author":"AM Kaufmann","year":"2007","unstructured":"Kaufmann, A. M. & Krise, J. P. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J. Pharm. Sci. 96, 729\u2013746 (2007).","journal-title":"J. Pharm. Sci."},{"key":"1227_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","volume":"24","author":"B Zhitomirsky","year":"2016","unstructured":"Zhitomirsky, B. & Assaraf, Y. G. Lysosomes as mediators of drug resistance in cancer. Drug Resist. Updat. 24, 23\u201333 (2016).","journal-title":"Drug Resist. Updat."},{"key":"1227_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1124\/dmd.112.050054","volume":"41","author":"F Kazmi","year":"2013","unstructured":"Kazmi, F. et al. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug Metab. Dispos. 41, 897\u2013905 (2013).","journal-title":"Drug Metab. Dispos."},{"key":"1227_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.30","volume":"3","author":"Y Adar","year":"2012","unstructured":"Adar, Y. et al. Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death Dis. 3, e293 (2012).","journal-title":"Cell Death Dis."},{"key":"1227_CR5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.18632\/oncotarget.2732","volume":"6","author":"B Zhitomirsky","year":"2015","unstructured":"Zhitomirsky, B. & Assaraf, Y. G. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance. Oncotarget 6, 1143\u20131156 (2015).","journal-title":"Oncotarget"},{"key":"1227_CR6","doi-asserted-by":"publisher","unstructured":"Zhitomirsky, B. & Assaraf, Y. G. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.15155 (2017)","DOI":"10.18632\/oncotarget.15155"},{"key":"1227_CR7","first-page":"3","volume":"2","author":"B Zhitomirsky","year":"2015","unstructured":"Zhitomirsky, B. & Assaraf, Y. G. The role of cytoplasmic-to-lysosomal pH gradient in hydrophobic weak base drug sequestration in lysosomes. Cancer Cell Microenviron. 2, 3\u20139 (2015).","journal-title":"Cancer Cell Microenviron."},{"key":"1227_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science. 325, 473\u2013477 (2009).","journal-title":"Science."},{"key":"1227_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ncb3114","volume":"17","author":"DL Medina","year":"2015","unstructured":"Medina, D. L. et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17, 288\u2013299 (2015).","journal-title":"Nat. Cell Biol."},{"key":"1227_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3565","volume":"14","author":"C Settembre","year":"2013","unstructured":"Settembre, C., Fraldi, A., Medina, D. L. & Ballabio, A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14, 283\u2013296 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1227_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","volume":"21","author":"DL Medina","year":"2011","unstructured":"Medina, D. L. et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell. 21, 421\u2013430 (2011).","journal-title":"Dev. Cell."},{"key":"1227_CR12","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","volume":"20","author":"M Palmieri","year":"2011","unstructured":"Palmieri, M. et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20, 3852\u20133866 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1227_CR13","doi-asserted-by":"publisher","unstructured":"Roczniak-Ferguson, A. et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. https:\/\/doi.org\/10.1126\/scisignal.2002790 (2012)","DOI":"10.1126\/scisignal.2002790"},{"key":"1227_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"168","author":"M Laplate","year":"2012","unstructured":"Laplate, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 168, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"1227_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095\u20131108 (2012).","journal-title":"EMBO J."},{"key":"1227_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1083\/jcb.201209135","volume":"200","author":"JA Martina","year":"2013","unstructured":"Martina, J. A. & Puertollano, R. Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes. J. Cell Biol. 200, 475\u2013491 (2013).","journal-title":"J. Cell Biol."},{"key":"1227_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4161\/auto.19653","volume":"8","author":"JA Martina","year":"2012","unstructured":"Martina, J. A., Chen, Y., Gucek, M. & Puertollano, R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903\u2013914 (2012).","journal-title":"Autophagy"},{"key":"1227_CR18","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1158\/0008-5472.CAN-05-0269","volume":"65","author":"MS Ostenfeld","year":"2005","unstructured":"Ostenfeld, M. S. et al. Effective tumor cell death by \u03c3-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res. 65, 8975\u20138983 (2005).","journal-title":"Cancer Res."},{"key":"1227_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4161\/auto.5774","volume":"4","author":"MS Ostenfeld","year":"2008","unstructured":"Ostenfeld, M. S. et al. Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation. Autophagy 4, 487\u2013499 (2008).","journal-title":"Autophagy"},{"key":"1227_CR20","first-page":"3774","volume":"51","author":"JM Olsson","year":"1991","unstructured":"Olsson, J. M. & Daliner, G. Lipid compositions of intracellular membranes isolated from rat liver nodules in Wistar rats. Cancer Res. 51, 3774\u20133780 (1991).","journal-title":"Cancer Res."},{"key":"1227_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.4","volume":"6","author":"P Nowak-Sliwinska","year":"2015","unstructured":"Nowak-Sliwinska, P. et al. Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition. Cell Death Dis. 6, e1641 (2015).","journal-title":"Cell Death Dis."},{"key":"1227_CR22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"1227_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak, Y. et al. Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290\u2013303 (2010).","journal-title":"Cell"},{"key":"1227_CR24","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen, C. C. et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023\u20138032 (2009).","journal-title":"J. Biol. Chem."},{"key":"1227_CR25","doi-asserted-by":"publisher","first-page":"29415","DOI":"10.1074\/jbc.272.47.29415","volume":"272","author":"T Sugimoto","year":"1997","unstructured":"Sugimoto, T., Stewart, S. & Guan, K. L. The calcium\/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase. J. Biol. Chem. 272, 29415\u201329418 (1997).","journal-title":"J. Biol. Chem."},{"key":"1227_CR26","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1158\/1078-0432.CCR-11-1667","volume":"17","author":"KJ Gotink","year":"2011","unstructured":"Gotink, K. J. et al. Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance. Clin. Cancer Res. 17, 7337\u20137346 (2011).","journal-title":"Clin. Cancer Res."},{"key":"1227_CR27","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.1021\/ja800516w","volume":"130","author":"MJ Parry","year":"2008","unstructured":"Parry, M. J. et al. High-affinity small molecule-phospholipid complex formation: binding of siramesine to phosphatidic acid. J. Am. Chem. Soc. 130, 12953\u201312960 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"1227_CR28","doi-asserted-by":"publisher","first-page":"e0153526","DOI":"10.1371\/journal.pone.0153526","volume":"11","author":"Z Li","year":"2016","unstructured":"Li, Z. et al. Ammonia induces autophagy through Dopamine receptor D3 and MTOR. PLoS One 11, e0153526 (2016).","journal-title":"PLoS One"},{"key":"1227_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1083\/jcb.201306041","volume":"203","author":"C Betz","year":"2013","unstructured":"Betz, C. & Hall, M. N. Where is mTOR and what is it doing there? J. Cell Biol. 203, 563\u2013574 (2013).","journal-title":"J. Cell Biol."},{"key":"1227_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2012","unstructured":"Zoncu, R., Sabatini, D. M. & Efeyan, A. mTOR: from growth signal to diabetes and cancer. Nat. Rev. Mol. Cell Biol. 12, 21\u201335 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1227_CR31","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1207056","volume":"334","author":"R Zoncu","year":"2011","unstructured":"Zoncu, R. et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+\u2013ATPase. Science 334, 678\u2013683 (2011).","journal-title":"Science"},{"key":"1227_CR32","doi-asserted-by":"publisher","first-page":"19195","DOI":"10.1039\/c1cp22484k","volume":"13","author":"OG Mouritsen","year":"2011","unstructured":"Mouritsen, O. G. Lipidology and lipidomics\u2013\u2013quo vadis? A new era for the physical chemistry of lipids. Phys. Chem. Chem. Phys. 13, 19195 (2011).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"1227_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1432-1033.1995.tb20352.x","volume":"228","author":"S Drori","year":"1995","unstructured":"Drori, S., Eytan, G. D. & Assaraf, Y. G. Potentiation of anticancer\u2010drug cytotoxicity by multidrug\u2010resistance chemosensitizers involves alterationsin membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. 228, 1020\u20131029 (1995).","journal-title":"Eur. J. Biochem."},{"key":"1227_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1432-1327.1999.00037.x","volume":"259","author":"R Regev","year":"1999","unstructured":"Regev, R., Assaraf, Y. G. & Eytan, G. D. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug- resistant cells. Eur. J. Biochem. 259, 18\u201324 (1999).","journal-title":"Eur. J. Biochem."},{"key":"1227_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin, D. A. & Sabatini, D. M. Defining the role of mTOR in cancer. Cancer Cell. 12, 9\u201322 (2007).","journal-title":"Cancer Cell."},{"key":"1227_CR36","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.12688\/f1000research.9207.1","volume":"5","author":"J Xie","year":"2016","unstructured":"Xie, J., Wang, X. & Proud, C. G. mTOR inhibitors in cancer therapy. F1000Research 5, 2078 (2016).","journal-title":"F1000Research"},{"key":"1227_CR37","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1021\/la9006982","volume":"25","author":"G Gopalakrishnan","year":"2009","unstructured":"Gopalakrishnan, G., Rouiller, I., Colman, D. R. & Lennox, R. B. Supported bilayers formed from different phospholipids on spherical silica substrates. Langmuir 25, 5455\u20135458 (2009).","journal-title":"Langmuir"},{"key":"1227_CR38","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1021\/la00011a058","volume":"11","author":"J R\u00e4dler","year":"1995","unstructured":"R\u00e4dler, J., Strey, H. & Sackmann, E. Phenomenology and kinetics of lipid bilayer spreading on hydrophilic surfaces. Langmuir 11, 4539\u20134548 (1995).","journal-title":"Langmuir"},{"key":"1227_CR39","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/nar\/17.15.6419","volume":"17","author":"E Schreiber","year":"1989","unstructured":"Schreiber, E., Matthias, P., M\u00fcller, M. M. & Schaffner, W. Rapid detection of octamer binding proteins with \u201cmini extracts\u201d, prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).","journal-title":"Nucleic Acids Res."},{"key":"1227_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.39","volume":"5","author":"S Raz","year":"2014","unstructured":"Raz, S. et al. Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest. Cell Death Dis. 5, e1067 (2014).","journal-title":"Cell Death Dis."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1227-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:06:17Z","timestamp":1672671977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1227-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["1227"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1227-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1191"}}